Swk Holdings Corp. (SWKH)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
SWKH Chart
Here's Why Stanley Black & Decker (SWK) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Is Stanley Black & Decker (SWK) Up 3.9% Since Last Earnings Report?
Stanley Black & Decker (SWK) reported earnings 30 days ago. What's next for the stock?
SWK vs. TTNDY: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Manufacturing - Tools & Related Products sector might want to consider either Stanley Black & Decker (SWK) or Techtronic Industries Co. (TTNDY). But which of these two stocks presents investors with the better value opportunity right now?
Swk Holdings Corp. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 7 | $107.29 | $111.3 | $4.01 | 3.74% |
 Kevin Kroskey True Wealth Design LLC | 5 | $76.2 | $79.5 | $3.3 | 4.33% |
Swk Holdings Corp. (SWKH) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Swk Holdings Corp. ever had a stock split?
Swk Holdings Corp. Profile
| Capital Markets Industry | Financials Sector | Jody. D Staggs CEO | NASDAQ (NMS) Exchange | 78501P203 CUSIP |
| US Country | 24 Employees | - Last Dividend | 24 Apr 2025 Last Split | 22 Sep 1999 IPO Date |
Overview
SWK Holdings Corporation, headquartered in Dallas, Texas, is a specialized financial service and asset management firm operating predominantly within the United States. Initially known as Kana Software, Inc., the company underwent a name change to SWK Holdings Corporation in December 2009. Since its inception in 1996, SWK Holdings has distinguished itself by focusing on the life sciences sector, providing a unique blend of financial solutions and services to a diversified client base. The company functions through two main divisions: Finance Receivables and Pharmaceutical Development, catering to a wide array of needs in the life science community, including biotechnology, medical devices, diagnostics, animal health, and pharmaceuticals.
Products and Services
-
Finance Receivables
This segment of SWK Holdings offers tailored financing solutions targeting a broad spectrum of life science companies and inventors. The clientele encompasses entities from the biotechnology, medical device, diagnostics, animal health, and pharmaceutical industries, among others. By providing flexible financing options, SWK Holdings supports the growth and advancement of companies and technologies within these sectors. Additionally, this segment extends non-discretionary investment advisory services to institutional clients, managing accounts specifically geared towards investments in life science finance.
-
Pharmaceutical Development
SWK Holdings' Pharmaceutical Development segment delivers wide-ranging services in pharmaceutical development, formulation, and manufacturing. It is notably recognized for the Peptelligence platform, a proprietary oral drug delivery technology that offers innovative formulation solutions. The segment’s capabilities facilitate the development process for clients, from conceptualization to final product creation, encompassing both development services and formulation technologies. Furthermore, SWK Holdings engages in the intellectual property licensing business, leveraging its developments and technologies to establish partnerships and collaborations within the industry.
